SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-004360
Filing Date
2022-06-14
Accepted
2022-06-14 16:05:19
Documents
15
Period of Report
2022-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT vnrx_8k.htm   iXBRL 8-K 54187
2 2015 STOCK INCENTIVE PLAN, AS AMENDED vnrx_ex101.htm EX-10.1 127723
  Complete submission text file 0001477932-22-004360.txt   342302

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20220613.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20220613_lab.xml EX-101.LAB 15320
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20220613_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20220613_pre.xml EX-101.PRE 9743
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20220613_def.xml EX-101.DEF 2103
9 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3699
Mailing Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 221014729
SIC: 2835 In Vitro & In Vivo Diagnostic Substances